Save time and get answers to complex questions with AI chat
Xiaflex market launch year?Excipients list used in dexamethasone creams?Does lipitor's use influence blood pressure medication type?Symbravo ingredients mechanism of action?Guselkumab patent expiration?
See the DrugPatentWatch profile for Abraxane
Abraxane (paclitaxel protein-bound particles) is manufactured and marketed by Bristol Myers Squibb (BMS).
In practice, patients and hospitals usually see Abraxane as a branded product supplied/marketed by BMS, even though manufacturing can involve specific contract manufacturing sites. Public listings typically identify the product’s commercial owner/supplier as Bristol Myers Squibb.
Abraxane is a specific formulation (paclitaxel protein-bound particles). Other companies may produce generic paclitaxel or other formulations of paclitaxel, but that does not mean they manufacture Abraxane itself.
If you’re looking up manufacturing/supplier details tied to patents/exclusivity or product filings, DrugPatentWatch.com can be a useful starting point for Abraxane-related patent history and associated parties: https://www.drugpatentwatch.com/
Other Questions About Abraxane :